Data extraction, Metabolomics, Molecular biology, Python Programming, SQL Server
Position at Seagen
Seagen is a global, multi-product biotechnology company dedicated to developing and commercializing transformative cancer medicines. As the industry leader in antibody-drug conjugate (ADC) technology, we pioneered a new generation in the science of harnessing antibodies to deliver cell-killing agents directly to cancer cells. Seagen’s dedication to improving the lives of cancer patients goes beyond science, and we believe that every employee has a role in contributing to this mission. By working together with a shared dedication and diverse perspectives, we are able to reach our full potential and make a real difference in the world. Seagen is a fast-growing company and has an abundance of opportunities available for you to grow your career. Put your passion to work at Seagen and join us!
Position Summary:
The BioProcess Development department at Seagen is seeking a highly motivated individual to work in the Cell Line Development (CLD) group. The Research Associate will support development of cell lines used to produce therapeutic proteins for clinical trials and future commercial applications while engaging cutting-edge technologies to characterize and advance our platform. The CLD team uses modern molecular biology and aseptic cell cultures techniques to create recombinant CHO cell lines for biologics production. As a key stage-gate between research and bioprocess development, CLD functionality is critical to the establishment and advancement of CMC project timelines and deliverables. The CLD team works in a highly collaborative, cross functional CMC setting involving many functional areas.
Principal Responsibilities:
Requirements:
Desired Skills:
Seagen Inc. is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. The company, headquartered in Bothell, Washington (a suburb of Seattle), is the industry leader in antibody-drug conjugates or ADCs.